跳至主要内容
临床试验/jRCTs071200026
jRCTs071200026招募中不适用

Study of sentinel lymph node for uterine cancer

未提供0 个研究点目标入组 540 人开始时间: 2020年11月6日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
540
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Single Arm Study
干预模型
Single Assignment
主要目的
Treatment Purpose
盲法
Open(masking Not Used)

入排标准

年龄范围
20age old over 至 No limit(—)
性别
Female

入选标准

  • Cervical cancer FIGO stage IA - IB 1
  • Endometrial cancer FIGO stage I - II
  • pathological type (cervical cancer) : SCC, adenocarcinoma, adenosquamous cell carcinoma
  • pathological type (endometrial cancer) : endometrioid carcinoma, serous carcinoma, clear cell carcinoma, carcinosarcoma
  • no lymph node swelling (preoperative CT or MRI)
  • patients age : 20age old over
  • ECOG Performance Status, PS: 0 or 1
  • no radiotherapy, chemotherapy and surgery (not including conization)
  • Patients who have no major organs dysfunction
  • Patients who have written consent from the patient

排除标准

  • Psychosis or psychiatric symptoms were judged to be difficult to participate in the study
  • Other cases inappropriate judged by medical doctor

结局指标

主要结局

-

Complication due to pelvic lymphadenectomy (lower extremity lymphedema, lymphocele, and ileus)

次要结局

未报告次要终点

研究者

发起方
未提供

相似试验